Abstract:Background The neuropathological hallmarks of Alzheimer’s disease (AD) are amyloid-β (Aβ) plaques and neurofibrillary tangles (NFTs). The amyloid cascade theory is the leading hypothesis of AD pathology. Aβ deposition precedes the aggregation of tau pathology and Aβ pathology precipitates tau pathology. Evidence also indicates the reciprocal interactions between amyloid and tau pathology. However, the detailed relationship between amyloid and tau pathology in AD remains elusive. Metformin might have a positive effect on cognitive impairments. However, whether metformin can reduce AD-related pathologies is still unconclusive. Methods Brain extracts containing tau aggregates were unilaterally injected into the hippocampus and the overlying cerebral cortex of 9-month-old APPswe/PS1DE9 (APP/PS1) mice and age-matched wild-type (WT) mice. Metformin was administrated in the drinking water for 2 months. Aβ pathology, tau pathology, plaque-associated microgliosis, and autophagy marker were analyzed by immunohistochemical staining and immunofluorescence analysis 2 months after injection of proteopathic tau seeds. The effects of metformin on both pathologies were explored. Results We observed tau aggregates in dystrophic neurites surrounding Aβ plaques (NP tau) in the bilateral hippocampi and cortices of tau-injected APP/PS1 mice but not WT mice. Aβ plaques promoted the aggregation of NP tau pathology. Injection of proteopathic tau seeds exacerbated Aβ deposits and decreased the number of microglia around Aβ plaques in the hippocampus and cortex of APP/PS1 mice. Metformin ameliorated the microglial autophagy impairment, increased the number of microglia around Aβ plaques, promoted the phagocytosis of NP tau, and reduced Aβ load and NP tau pathology in APP/PS1 mice. Conclusion These findings indicate the existence of the crosstalk between amyloid and NP tau pathology. Metformin promoted the phagocytosis of pathological Aβ and tau proteins by enhancing microglial autophagy capability. It reduced Aβ deposits and limited the spreading of NP tau pathology in APP/PS1 mice, which exerts a beneficial effect on both pathologies.

Formononetin Could Increase Soluble-Appα Secretion by Up-Regulating ADAM10 Level

Formononetin protects neurons against hypoxia-induced cytotoxicity through upregulation of ADAM10 and sAβPPα.

Formononetin Attenuates Aβ25-35-induced Cytotoxicity in HT22 Cells Via PI3K/Akt Signaling and Non-Amyloidogenic Cleavage of APP.

Neuroprotective effects of formononetin against NMDA-induced apoptosis in cortical neurons.

Formononetin attenuates high glucose-induced neurotoxicity by negatively regulating oxidative stress and mitochondrial dysfunction in Schwann cells via activation of SIRT3

Formononetin Ameliorates Cognitive Disorder Via PGC-1α Pathway in Neuroinflammation Conditions in High-Fat Diet-Induced Mice

Transcriptome Analysis of the Aged SAMP8 Mouse Model of Alzheimer’s Disease Reveals Novel Molecular Targets of Formononetin Protection

Transcriptome analysis of the aged SAMP8 mouse model of Alzheimer's disease reveals novel molecular targets of formononetin protection

Metformin Attenuates Plaque-Associated Tau Pathology and Reduces Amyloid-Β Burden in APP/PS1 Mice

Formononetin ameliorates the LPS-induced inflammatory response and apoptosis of neuronal cells via NF-κB/NLRP3 signaling pathway

Metformin Treatment Attenuates Tau Seeding in Neuritic Plaques

Formononetin Attenuates Atherosclerosis Via Regulating Interaction Between KLF4 and SRA in Apoe-/- Mice.

The Neuroprotective Effects of Formononetin: Signaling Pathways and Molecular Targets

Formononetin Attenuates IL-1β-Induced Apoptosis and NF-κB Activation in INS-1 Cells

Formononetin Protects Against Inflammation Associated with Cerebral Ischemia-Reperfusion Injury in Rats by Targeting the JAK2/STAT3 Signaling Pathway

Plant Natural Product Formononetin Protects Rat Cardiomyocyte H9c2 Cells Against Oxygen Glucose Deprivation and Reoxygenation Via Inhibiting ROS Formation and Promoting GSK-3β Phosphorylation.

Formononetin Recovered Injured Nerve Functions by Enhancing Synaptic Plasticity in Ischemic Stroke Rats

NeuroProtect, a Candidate Formula From Traditional Chinese Medicine, Attenuates Amyloid-β and Restores Synaptic Structures in APP/PS1 Transgenic Mice

Formononetin induces the mitochondrial apoptosis pathway in prostate cancer cells via downregulation of the IGF-1/IGF-1R signaling pathway

Inhibiting Gene Expression of Α3 Nicotinic Receptor in SH-SY5Y Cells with the Effects on APP Metabolism and Antioxidation in Alzheimer's Disease

Alpha-Secretase ADAM10 Regulation: Insights into Alzheimer’s Disease Treatment